Large B-Cell - Globe Thesis

Keyword [Large B-Cell] Result: 81 - 100 \| Page: 5 of 10
81.	The Clinical Significance Of T Cell Subgroups And NK Cell's Expression Level In Diffuse Large B-cell Lymphoma Patients
82.	Significance Of GSK-3β And β-catenin Protein Expression In The Tissues Of Diffuse Large B Cell Lymphoma
83.	Study On The Role Of Interleukin-9in Diffuse Large B-cell Lymphoma
84.	Treatment Outcomes And Dosimetric Evaluations In Patients With Primary Mediastinal Large B-cell Lymphoma Receiving Combined Modality Therapy And Intensity-modulated Radiotherapy
85.	Study On Immunephenotype, Antiapoptotic Properties And PI3K/Akt/mTOR Signalling Mechanism In Uygur Diffuse Large B Cell Lymphoma In Xinjiang
86.	Study Of Immunohistochemical Subgroups, Molecular Genetic Alterations And Their Correlations To Prognosis In Chinese Patients With Diffuse Large B Cell Lymphoma
87.	The Regulatory Effect And Underlying Mechanism Of JMJD3in Promoting Progress Of Diffuse Large B-cell Lymphoma
88.	Prognostic Values Of Novel Molecules In NF-κB Pathway Among Peripheral T Cell Lymphoma And Diffuse Large B Cell Lymphoma
89.	The Role Of Molecular Pathogenesis Of The Activation Of PI3K/AKT/mTOR Signaling Pathway And The Pre-clinical Study Of Targeted Therapy In Diffuse Large B Cell Lymphoma
90.	Clinical Studies Of Non-Hodgkins Lymphoma
91.	The Impact Of Expression Of Costimulatory Molecules In Peripheral Blood T Cells Among The Patients With DLBCL
92.	Clinical Significance Of Aberrant Genetic Alterations In Large B Cell Lymphomas
93.	Analysis Of Primary Extranodal Non-Hodgkin Lymphomas Of The Oral Cavity
94.	Prognostic Analysis Of HBV Infection In DLBCL And The Role Of T Cell-mediated Immunity
95.	Investigation On Aberrant Expression Of PI3K Catalytic Subunits And AKT Activation In DLBCL
96.	The Clinical And Experimental Study Of Mononuclear Phagocyte System In Diffuse Large B Cell Lymphoma
97.	To Investigate The Prognosis In Diffuse Large B-cell Lymphoma And Etiology Of Non-Hodgkin Lymphoma
98.	The Expression And Biological Function Of MicroRNA-224 In Diffuselarge B-cell Lymphoma
99.	Clinical Application ¹⁸F-FDG PET/CT In The Prognostic Prediction Of Diffuse Large B-cell Lymphoma
100.	Clinical Outcome And Dosimetric Analysis Of Radiotherapy For Patients With Waldeyer Ring Diffuse Large B-Cell Lymphoma
<<First <Prev Next> Last>> Jump to